| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |